绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02480 绿竹生物-B

未开盘 03-16 15:44:23

23.000

+0.000

0.00%

最高23.000	最低23.000	成交量8,600
今开23.000	昨收23.000	日振幅0.00%
总市值45.77亿	流通市值45.77亿	总股本1.99亿
成交额19.78万	换手率0.00%	流通股本1.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"绿竹生物-B","latestPrice":23,"timestamp":1773647063781,"preClose":23,"halted":0,"volume":8600,"delay":0,"changeRate":0,"floatShares":199000000,"shares":199000000,"eps":-0.833766,"marketStatus":"未开盘","change":0,"latestTime":"03-16 15:44:23","open":23,"high":23,"low":23,"amount":197800,"amplitude":0,"askPrice":23,"askSize":140600,"bidPrice":20.8,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.744022,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773711000000},"marketStatusCode":0,"adr":0,"listingDate":1683475200000,"exchange":"SEHK","adjPreClose":23,"openAndCloseTimeList":[[1773624600000,1773633600000],[1773637200000,1773648000000]],"volumeRatio":5.243902407049376,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02480","defaultTab":"news","newsList":[{"id":"2618679060","title":"绿竹生物-B盘中异动 急速下挫9.47%报22.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618679060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618679060?lang=zh_cn&edition=full","pubTime":"2026-03-09 15:25","pubTimestamp":1773041152,"startTime":"0","endTime":"0","summary":"2026年03月09日下午盘15时25分，绿竹生物-B股票出现异动，股价快速下挫9.47%。截至发稿，该股报22.000港元/股，成交量400股，换手率0.00%，振幅7.41%。资金方面，该股资金流入9160港元，流出0港元。绿竹生物-B股票所在的生物技术行业中，整体跌幅为2.73%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030915255297aadfda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030915255297aadfda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2616533513","title":"绿竹生物-B(02480.HK)拟3月18日举行董事会会议批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533513","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616533513?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:07","pubTimestamp":1772615223,"startTime":"0","endTime":"0","summary":"格隆汇3月4日丨绿竹生物-B(02480.HK)宣布，本公司将于2026年3月18日(星期三)举行董事会会议，以(其中包括)考虑及批准本集团截至2025年12月31日止年度的全年业绩以及考虑派发末期股息(如有)的建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260304/32044407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2610733306","title":"绿竹生物-B盘中异动 下午盘大幅下跌6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610733306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610733306?lang=zh_cn&edition=full","pubTime":"2026-02-10 15:01","pubTimestamp":1770706877,"startTime":"0","endTime":"0","summary":"2026年02月10日下午盘15时01分，绿竹生物-B股票出现波动，股价急速下挫6.93%。截至发稿，该股报20.400港元/股，成交量1800股，换手率0.00%，振幅6.93%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为3.44%。其相关个股中，复宏汉霖、亿腾嘉和、华生物-B涨幅较大，振幅较大的相关个股有复旦张江、复宏汉霖、愉悦集团，振幅分别为17.95%、13.72%、11.84%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021015011795408c94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021015011795408c94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"1173622669","title":"绿竹生物（2480）1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1173622669","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173622669?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:36","pubTimestamp":1770107799,"startTime":"0","endTime":"0","summary":"北京绿竹生物技术股份有限公司于2026年2月3日发布2026年1月股份变动月报表。报告期为2026年1月1日至2026年1月31日。报告显示，公司注册股本及已发行股份数均保持不变。月报同时披露，公司在2026年1月期间无购回、注销或新增发行股份的事项，也未出现股份期权或其他可转换证券的行使或授出。公司确认已符合法定的最低公众持股量要求，并严格遵守香港联合交易所有限公司证券上市规则及相关法律规定。报告由联席公司秘书刘斯宇签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480"],"gpt_icon":0},{"id":"1179582648","title":"北京绿竹生物技术（02480）11月无新增发行 股本结构维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1179582648","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179582648?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:07","pubTimestamp":1764580049,"startTime":"0","endTime":"0","summary":"北京绿竹生物技术股份有限公司于2025年12月1日发布11月股份变动月报表，报告期为截至2025年11月30日。公告显示，公司已发行股本维持不变，普通股H股数量合计202,449,032股，其中包括198,913,232股已发行股份及3,535,800股库存股份。公告同时强调，公司已根据香港联合交易所有限公司的相关上市规则以及相关法律法规安排本月股本变动及信息披露事宜，并由联席公司秘书刘斯宇签署确认。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480"],"gpt_icon":0},{"id":"2586294747","title":"绿竹生物-B盘中异动 早盘急速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586294747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586294747?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:46","pubTimestamp":1764121567,"startTime":"0","endTime":"0","summary":"2025年11月26日早盘09时46分，绿竹生物-B股票出现异动，股价急速下挫5.09%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.39%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126094607a711be40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126094607a711be40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2581412450","title":"绿竹生物-B盘中异动 下午盘大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581412450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581412450?lang=zh_cn&edition=full","pubTime":"2025-11-06 14:55","pubTimestamp":1762412108,"startTime":"0","endTime":"0","summary":"2025年11月06日下午盘14时55分，绿竹生物-B股票出现波动，股价急速拉升5.36%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为0.75%。绿竹生物-B公司简介：北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106145509a6e52a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106145509a6e52a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2576094358","title":"绿竹生物-B盘中异动 临近收盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576094358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576094358?lang=zh_cn&edition=full","pubTime":"2025-10-17 15:44","pubTimestamp":1760687051,"startTime":"0","endTime":"0","summary":"2025年10月17日临近收盘15时44分，绿竹生物-B股票出现异动，股价快速下跌5.74%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，药捷安康-B、轩竹生物-B、三叶草生物-B涨幅较大，振幅较大的相关个股有永泰生物-B股权、药捷安康-B、轩竹生物-B，振幅分别为57.35%、33.47%、20.55%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101715441194ceaee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101715441194ceaee8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2574156703","title":"绿竹生物-B(02480)于美国成功完成LZ901的I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2574156703","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574156703?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:05","pubTimestamp":1760007922,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B 公布，于美利坚合众国进行的 LZ901的I期临床试验已于2025年9月成功完成。根据于美国进行的LZ901的I期临床试验结果，LZ901疫苗高剂量组和低剂量组较安慰剂组而言，均表现出良好的安全性和免疫原性。LZ901于中华人民共和国的III期临床试验已达到临床预设目标，并取得符合预期的临床结果。截至本公告日期，LZ901的生物制品许可申请已获中国国家药品监督管理局受理，目前正在接受评估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2570202067","title":"绿竹生物-B(02480)：彭玲获委任为公司副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2570202067","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570202067?lang=zh_cn&edition=full","pubTime":"2025-09-25 17:15","pubTimestamp":1758791725,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B(02480)发布公告，公司执行董事、副董事长彭玲女士已获委任为公司副总经理。作为公司副总经理，彭玲女士将主要负责集团各项目的质量研究、质量控制及质量保证工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2566632589","title":"迫近现金红线核心品种难挑大梁，绿竹生物-B(02480)何时重返市场聚光灯下？","url":"https://stock-news.laohu8.com/highlight/detail?id=2566632589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566632589?lang=zh_cn&edition=full","pubTime":"2025-09-11 17:06","pubTimestamp":1757581609,"startTime":"0","endTime":"0","summary":"8月18日和19日，绿竹生物连续2个交易日收涨逾8%，期间最高股价触及28港元，创下公司股价近15个月以来的新高。即使此次公司核心品种披露重大利好，绿竹生物在8月19日的单日成交量仅为69600股，但这也是其8月至今的最高单日成交量。从成交量来看，绿竹生物依旧处在被市场遗忘的边缘。财报显示，绿竹生物当期现金及现金等价物合计9921.9万元，同比减少29.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2518571320","title":"绿竹生物-B03月11日主力净流入19万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518571320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518571320?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:16","pubTimestamp":1741680990,"startTime":"0","endTime":"0","summary":"03月11日, 绿竹生物-B股价涨6.58%，报收24.30元，成交金额102万元，换手率0.02%，振幅6.14%，量比32.87。绿竹生物-B今日主力资金净流入19万元，上一交易日主力净流出0万元。该股近5个交易日上涨15.99%，主力资金累计净流入19万元；近20日主力资金累计净流入19万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165944abf609cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165944abf609cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2518175326","title":"绿竹生物-B盘中异动 快速上涨6.58%报24.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518175326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518175326?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:50","pubTimestamp":1741661433,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘10时50分，绿竹生物-B股票出现异动，股价快速拉升6.58%。截至发稿，该股报24.300港元/股，成交量2600股，换手率0.00%，振幅5.70%。资金方面，该股资金流入6.27万港元，流出0港元。绿竹生物-B股票所在的生物技术行业中，整体涨幅为1.44%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110503398a345d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110503398a345d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2518298889","title":"绿竹生物-B盘中异动 快速上涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518298889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518298889?lang=zh_cn&edition=full","pubTime":"2025-03-10 13:33","pubTimestamp":1741584786,"startTime":"0","endTime":"0","summary":"2025年03月10日下午盘13时33分，绿竹生物-B股票出现波动，股价急速上涨5.86%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为2.67%。绿竹生物-B公司简介：北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310133306963fba33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310133306963fba33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2517215021","title":"绿竹生物-B盘中异动 急速下挫8.89%报20.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517215021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517215021?lang=zh_cn&edition=full","pubTime":"2025-03-07 13:00","pubTimestamp":1741323604,"startTime":"0","endTime":"0","summary":"2025年03月07日下午盘13时00分，绿竹生物-B股票出现异动，股价快速下跌8.89%。截至发稿，该股报20.500港元/股，成交量600股，换手率0.00%，振幅8.67%。资金方面，该股资金流入4490港元，流出8200港元。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.37%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307130004abec66be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307130004abec66be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2513174798","title":"绿竹生物-B盘中异动 快速跳水7.80%报20.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513174798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513174798?lang=zh_cn&edition=full","pubTime":"2025-02-24 10:00","pubTimestamp":1740362449,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘10时00分，绿竹生物-B股票出现异动，股价快速跳水7.80%。截至发稿，该股报20.700港元/股，成交量400股，换手率0.00%，振幅0.00%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，永泰生物-B、腾盛博药-B、昭衍新药涨幅较大，振幅较大的相关个股有永泰生物-B、腾盛博药-B、华昊中天医药-B，振幅分别为19.78%、17.72%、14.93%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224100049989034b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224100049989034b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2512463766","title":"绿竹生物-B盘中异动 早盘大幅下跌7.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512463766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512463766?lang=zh_cn&edition=full","pubTime":"2025-02-20 10:20","pubTimestamp":1740018023,"startTime":"0","endTime":"0","summary":"2025年02月20日早盘10时20分，绿竹生物-B股票出现异动，股价大幅下跌7.43%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.42%。绿竹生物-B公司简介：北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220102023988bbab7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220102023988bbab7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2511582766","title":"绿竹生物-B盘中异动 股价大跌9.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511582766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511582766?lang=zh_cn&edition=full","pubTime":"2025-02-14 14:44","pubTimestamp":1739515472,"startTime":"0","endTime":"0","summary":"2025年02月14日下午盘14时44分，绿竹生物-B股票出现异动，股价快速跳水9.55%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为3.23%。其相关个股中，维亚生物、华领医药-B、晶泰控股-P涨幅较大，振幅较大的相关个股有维亚生物、方达控股、中国抗体-B，振幅分别为20.41%、18.24%、14.29%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214144432962299c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214144432962299c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2510580885","title":"又一款国产带状疱疹疫苗申报上市 中老年人的接种市场仍待撬开","url":"https://stock-news.laohu8.com/highlight/detail?id=2510580885","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510580885?lang=zh_cn&edition=full","pubTime":"2025-02-10 14:11","pubTimestamp":1739167895,"startTime":"0","endTime":"0","summary":"【又一款国产带状疱疹疫苗申报上市 中老年人的接种市场仍待撬开】2月9日晚间，绿竹生物（02480.HK）发布了其重组带状疱疹疫苗LZ901上市申请获得国家药监局受理消息。如顺利上市的话，这款疫苗将成为在国内上市的第三款带状疱疹疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502103314877975.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502103314877975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2510607276","title":"绿竹生物-B：LZ901生物制品许可申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2510607276","media":"新浪网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510607276?lang=zh_cn&edition=full","pubTime":"2025-02-10 09:14","pubTimestamp":1739150070,"startTime":"0","endTime":"0","summary":"绿竹生物-B发布公告，于近日，集团的重组带状疱疹疫苗及核心产品LZ901的生物制品许可申请获得了中国国家药品监督管理局受理。LZ901是集团自主开发的重组带状疱疹疫苗，并且是集团的核心产品，旨在预防年龄为40岁及以上成人带状疱疹及带状疱疹引致的相关并发症的发生。LZ901于中国的III期临床试验已达到临床预设目标，并取得符合预期的临床结果。请读者仅作参考，并请自行承担全部责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093226961d49e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093226961d49e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://luzhubiotech.com","stockEarnings":[{"period":"1week","weight":-0.0336},{"period":"1month","weight":0.0052},{"period":"3month","weight":-0.012},{"period":"6month","weight":-0.0612},{"period":"1year","weight":-0.0763},{"period":"ytd","weight":-0.0254}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0237},{"period":"6month","weight":-0.0399},{"period":"1year","weight":0.0782},{"period":"ytd","weight":0.0079}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京绿竹生物技术股份有限公司是一家主要从事疫苗及治疗性生物制剂的研究、开发及生产的中国公司。该公司还从事开发创新型人用疫苗及治疗性生物制剂，以预防及控制传染病以及治疗癌症及自身免疫性疾病。该公司的产品包括临床阶段的在研产品，以及临床前阶段的在研产品。核心产品LZ901，主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司主要在国内市场开展其业务","exchange":"SEHK","name":"绿竹生物-B","nameEN":"LUZHU BIOTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿竹生物-B,02480,绿竹生物-B股票,绿竹生物-B股票老虎,绿竹生物-B股票老虎国际,绿竹生物-B行情,绿竹生物-B股票行情,绿竹生物-B股价,绿竹生物-B股市,绿竹生物-B股票价格,绿竹生物-B股票交易,绿竹生物-B股票购买,绿竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}